Maximizing the value of the open label extension phase of randomized clinical trials

被引：0
|
作者：
Howard Trachtman
Rosanna Coppo
Moin Saleem
Alex Mercer
Radko Komers
机构：
[1] University of Michigan,Department of Pediatrics
[2] Fondazione Ricerca Molinette,Children’s Renal Unit, Bristol Medical School
[3] Ospedale Regina Margherita,undefined
[4] University of Bristol,undefined
[5] JAMCO Pharma Consulting AB,undefined
[6] Travere Therapeutics,undefined
[7] Inc.,undefined
来源：
Journal of Nephrology | 2023年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1561 / 1563
页数：2
相关论文
共 50 条
  • [1] Maximizing the value of the open label extension phase of randomized clinical trials
    Trachtman, Howard
    Coppo, Rosanna
    Saleem, Moin
    Mercer, Alex
    Komers, Radko
    [J]. JOURNAL OF NEPHROLOGY, 2023, 36 (06) : 1561 - 1563
  • [2] Does open label extension trials impact patients to enroll in clinical trials?
    Hank, Nicole C.
    Chung, Steve S.
    [J]. EPILEPSIA, 2006, 47 : 252 - 252
  • [3] Considerations for open-label randomized clinical trials: Design, conduct, and analysis
    Higgins, Karen M.
    Levin, Gregory
    Busch, Robert
    [J]. CLINICAL TRIALS, 2024,
  • [4] Maximizing scientific knowledge from randomized clinical trials
    Gustafsson, Finn
    Atar, Dan
    Pitt, Bertram
    Zannad, Faiez
    Pfeffer, Marc A.
    [J]. AMERICAN HEART JOURNAL, 2010, 159 (06) : 937 - 943
  • [5] Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy
    Wagner, Kathryn R.
    Abdel-Hamid, Hoda Z.
    Mah, Jean K.
    Campbell, Craig
    Guglieri, Michela
    Muntoni, Francesco
    Takeshima, Yasuhiro
    McDonald, Craig M.
    Kostera-Pruszczyk, Anna
    Karachunski, Peter
    Butterfield, Russell J.
    Mercuri, Eugenio
    Fiorillo, Chiara
    Bertini, Enrico S.
    Tian, Cuixia
    Statland, Jeffery
    Sadosky, Alesia B.
    Purohit, Vivek S.
    Sherlock, Sarah P.
    Palmer, Jeffrey P.
    Binks, Michael
    Charnas, Lawrence
    Marraffino, Shannon
    Wong, Brenda L.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 (06) : 492 - 502
  • [6] The Value of Randomized Clinical Trials in Ophthalmology
    Chew, Emily Y.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (04) : 575 - 578
  • [7] Value of randomized clinical trials - Reply
    Kurtzman, NA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : 907 - 907
  • [8] A potential bias in safety evaluation during open-label extensions of randomized clinical trials
    Rothman, KJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (05) : 295 - 298
  • [9] What we can learn from open-label extensions of randomized clinical trials
    Cummings, JL
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (01) : 18 - 19
  • [10] Safety patterns with ozanimod in phase 3 and open-label extension trials in patients with relapsing multiple sclerosis
    Selmaj, K. W.
    Ziemssen, T.
    Comi, G.
    Hartung, H. P.
    Singal, M.
    Thorpe, A.
    Riolo, J. V.
    Cheng, C. Y.
    Sheffield, J. K.
    Krakovich, A.
    Vermersch, P.
    Cree, B. A. C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 324 - 324
12345